These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1633307)

  • 1. Genetically engineered toxins in perspective.
    Olsnes S; Frankel AE
    Targeted Diagn Ther; 1992; 7():465-77. PubMed ID: 1633307
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic engineering of immunotoxins.
    Chandler JC; Frankel AE; Tagge EP
    Semin Pediatr Surg; 1996 Aug; 5(3):206-11. PubMed ID: 8858768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice.
    Smallshaw JE; Ghetie V; Rizo J; Fulmer JR; Trahan LL; Ghetie MA; Vitetta ES
    Nat Biotechnol; 2003 Apr; 21(4):387-91. PubMed ID: 12627168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxigenics.
    Evans GA
    Semin Cell Biol; 1991 Feb; 2(1):71-9. PubMed ID: 1954346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxins and cancer therapy.
    Li Z; Yu T; Zhao P; Ma J
    Cell Mol Immunol; 2005 Apr; 2(2):106-12. PubMed ID: 16191416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotoxins and toxin constructs in the treatment of leukemia and lymphoma.
    Rosenblum M
    Adv Pharmacol; 2004; 51():209-28. PubMed ID: 15464911
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotoxins and cytokine toxin fusion proteins.
    Strom TB; Anderson PL; Rubin-Kelley VE; Williams DP; Kiyokawa T; Murphy JR
    Semin Immunol; 1990 Nov; 2(6):467-79. PubMed ID: 2104283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering and biological characterization of VB6-845, an anti-EpCAM immunotoxin containing a T-cell epitope-depleted variant of the plant toxin bouganin.
    Cizeau J; Grenkow DM; Brown JG; Entwistle J; MacDonald GC
    J Immunother; 2009; 32(6):574-84. PubMed ID: 19483652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered toxins.
    Targeted Diagn Ther; 1992; 7():1-494. PubMed ID: 1633286
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure-function analysis of cysteine-engineered entomopathogenic toxins.
    Schwartz JL; Masson L
    Methods Mol Biol; 2000; 145():101-13. PubMed ID: 10820718
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant targeted proteins for biotherapy.
    Ahmad A; Law K
    Mol Biother; 1990 Jun; 2(2):67-73. PubMed ID: 2194500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxin therapy of cancer.
    Frankel AE
    Oncology (Williston Park); 1993 May; 7(5):69-78; discussion 79-80, 83-6. PubMed ID: 8512787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical engineering of immunotoxins for ex vivo bone marrow transplantation and in vivo leukemia treatment.
    Carayon P; Casellas P; Jansen FK
    Targeted Diagn Ther; 1989; 2():41-52. PubMed ID: 2519549
    [No Abstract]   [Full Text] [Related]  

  • 15. Taming ricin toxin.
    Kreitman RJ
    Nat Biotechnol; 2003 Apr; 21(4):372-4. PubMed ID: 12665820
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies come back from the brink.
    Holliger P; Hoogenboom H
    Nat Biotechnol; 1998 Nov; 16(11):1015-6. PubMed ID: 9831027
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotoxins: status and prospects.
    Spooner RA; Lord JM
    Trends Biotechnol; 1990 Jul; 8(7):189-93. PubMed ID: 1366624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxins containing ricin or its A chain.
    Vitetta ES; Thorpe PE
    Semin Cell Biol; 1991 Feb; 2(1):47-58. PubMed ID: 1954343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology evaluation: SGN-15, Seattle Genetics Inc.
    Smith S
    Curr Opin Mol Ther; 2001 Jun; 3(3):295-302. PubMed ID: 11497354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research.
    Bolon B
    Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):154-61. PubMed ID: 15504150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.